Our Company

MBL International Corporation (MBLI)

front side

Established in 1993, MBL International Corporation (MBLI) is a leading life science company focused on providing high quality, innovative, solutions-based products for both life science research and clinical diagnostics. Our products are used widely in academic research institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories.

MBLI develops, manufactures, and markets a broad portfolio of monoclonal and polyclonal antibodies, MHC tetramers, fluorescent and recombinant proteins and ELISA kits for research related to allergy, apoptosis, autophagy, cancer, epigenetics, immunology, and neuroscience. We have recently added new products including flow cytometryexosome research products, and 3D cell culture (NCP) products to our portfolio.

In 2008, our diagnostic portfolio was extended with the acquisition of Bion Enterprises, Ltd adding an immunofluorence assay product line, further strengthening our autoimmune and infectious disease product offering. Bion Enterprises, Ltd. was founded in 1978 to address a market need of high quality IFA products for hospitals and reference labs.

We are committed to making your science more efficient and effective. From order to delivery and every point in between and after, we deliver uncompromising support through our scientific sales, customer service, and technical support teams to ensure that you get the product and assistance when you need it. Our extensive distribution network reaches out to over 50 countries so no matter where you are located our products and services are nearby.